Mayo Clinic | Strategic Alliance Partners

Latest from Mayo Clinic


Dr. Sekulic on Vismodegib for Basal-Cell Nevus Syndrome

November 06, 2012

Aleksandar Sekulic, MD, PhD, from the Mayo Clinic, Scottsdale, AZ, discusses the administration of vismodegib for the treatment and prevention of basal-cell carcinoma in patients with basal-cell nevus syndrome.

Update on Bone Disease in Multiple Myeloma

December 19, 2011

Bone disease occurs in about 84% of patients with multiple myeloma and is responsible for a great deal of morbidity, including pain, hypercalcemia, compromised quality of life, and pathological fracture.